DR. LALSINGH & PARTNERS
CLARENDON MEDICAL, CLARENDON MEDICAL, 35 NORTHLAND AVENUE, LONDONDERRYHF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
HF 4 | 2010 | 14 | 17 | 82.4% | |
HF 4 | 2011 | 15 | 23 | 65.2% | |
HF 4 | 2012 | 17 | 26 | 65.4% | |
HF 4 | 2013 | 15 | 21 | 71.4% | |
HF004 | 2014 | 21 | 28 | 75.0% | |
HF004 | 2015 | 20 | 27 | 74.1% | |
HF004 | 2016 | 28 | 37 | 75.7% | |
HF004 | 2017 | 45 | 59 | 76.3% | |
HF004 | 2018 | 51 | 63 | 81.0% | |
HF004 | 2019 | 48 | 58 | 82.8% | |
HF004 | 2020 | 45 | 52 | 86.5% | |
HF004 | 2021 | 45 | 53 | 84.9% |